Clarelli, F <br/><br/>
Pharmacogenetic study of long-term response to interferon-β treatment in multiple sclerosis.  [electronic resource] 

 -  The pharmacogenomics journal  01 2017 
 - 84-91 p.  digital 
<br/><br/> Publication Type: Journal Article; Meta-Analysis 
<br/><br/><label>ISSN: </label>1473-1150 
<br/><br/><label>Standard No.: </label>10.1038/tpj.2015.85  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Case-Control Studies<br/>Cell Adhesion Molecules, Neuronal--genetics<br/>Female<br/>Gene Expression Profiling<br/>Genome-Wide Association Study<br/>Genotype<br/>Humans<br/>Immunologic Factors--adverse effects<br/>Interferon-beta--adverse effects<br/>Italy<br/>Male<br/>Middle Aged<br/>Multiple Sclerosis--diagnosis<br/>Pharmacogenetics<br/>Pharmacogenomic Testing--methods<br/>Pharmacogenomic Variants<br/>Phenotype<br/>Polymorphism, Single Nucleotide<br/>Quantitative Trait Loci<br/>Receptors, Kainic Acid--genetics<br/>Receptors, Metabotropic Glutamate--genetics<br/>Time Factors<br/>Treatment Outcome<br/>Young Adult<br/>GluK2 Kainate Receptor